DHANLYRA Trademark
Trademark Overview
On Friday, October 10, 2025, a trademark application was filed for DHANLYRA with the United States Patent and Trademark Office. The USPTO has given the DHANLYRA trademark a serial number of 99436221. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, March 2, 2026. This trademark is owned by Kiniksa Pharmaceuticals, GmbH. The DHANLYRA trademark is filed in the Pharmaceutical Products category with the following description:
Anti-inflammatories; Cardiovascular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cardiac diseases and disorders; Pharmaceutical preparations for the treatment and prevention of immune-mediated diseases and disorders;; Pharmaceutical preparations for the treatment and prevention of rare diseases and disorders
General Information
| Serial Number | 99436221 |
| Word Mark | DHANLYRA |
| Filing Date | Friday, October 10, 2025 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Monday, March 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Anti-inflammatories; Cardiovascular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cardiac diseases and disorders; Pharmaceutical preparations for the treatment and prevention of immune-mediated diseases and disorders;; Pharmaceutical preparations for the treatment and prevention of rare diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 10, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Kiniksa Pharmaceuticals, GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | Zug 6300
CH |
Trademark Events
| Event Date | Event Description |
| Friday, October 10, 2025 | NEW APPLICATION ENTERED |
| Friday, October 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 27, 2026 | ASSIGNED TO EXAMINER |
| Monday, March 2, 2026 | SUSPENSION LETTER WRITTEN |
| Monday, March 2, 2026 | LETTER OF SUSPENSION E-MAILED |
| Monday, March 2, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, March 10, 2026 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, March 10, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 10, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
